Epidemiological profile of alopecia areata — own experience
, 2
Abstract
Introduction: Alopecia areata (AA) is a complex autoimmune condition that causes non-scarring hair loss. Incidence is estimated at 0.1-0.2% of the general population. The aim of this study is a retrospective analysis of the population of patients with alopecia areata in the years 2015–2019.
Material and methods: This is a retrospective cross-sectional study conducted through the analysis of clinical documentation data between 2015 and 2019. The study involved all the patients diagnosed with ICD10 L63 code for primary diagnosis of alopecia areata hospitalized in the Department of Dermatology, Paediatric Dermatology and the Oncology Medical University of Lodz.
Results: In the years 2015–2019 223 hospitalizations due to AA were reported. The number of female patients significantly dominated in both adult and paediatric populations: 73 girls, 38 boys, 86 women, 26 men. The results show that most of the patients lived in a city, the mean age was 7.5 (95CL = 6.5–8.6) years among children and 40 (95CL= 36.8–42.9) among adults. The most common medical diagnosis of alopecia areata based on ICD10 is Unspecified Alopecia areata — 131 cases, then other forms of AA — 34 cases, alopecia universalis 13 cases, ophiasis 4 cases.
Conclusions: Current results indicate that the predisposition for AA mainly concerns women after the fourth decade of life. The prevalence of hospitalization on the female side also works in the population of children with the average age spanning across 6–10 years of age. An increase in hospitalization due to AA after 2015 was observed. Most diagnoses relate to the non-specific form of alopecia areata.
Keywords: alopecia areatachildrenadultepidemiology
References
- Strazzulla L, Wang E, Avila L, et al. Alopecia areata. Journal of the American Academy of Dermatology. 2018; 78(1): 1–12.
- Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012; 166(5): 916–926.
- Mirzoyev SA, Schrum AG, Davis MDP, et al. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Invest Dermatol. 2014; 134(4): 1141–1142.
- Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015; 8: 397–403.
- Kamińska G, Brzezińska-Wcisło L, Lis A, et al. Analysis of alopecia areata treatment in a group of children at the Dermatological Department, Silesian Medical Academy in 1997-2001. Advances in Dermatology and Allergology. 2003; 20: 267–273.
- Safavi KH, Muller SA, Suman VJ, et al. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995; 70(7): 628–633.
- Jabbari A, Cerise JE, Chen JC, et al. Molecular signatures define alopecia areata subtypes and transcriptional biomarkers. EBioMedicine. 2016; 7: 240–247.
- Alshahrani AA, Al-Tuwaijri R, Abuoliat ZA, et al. Prevalence and Clinical Characteristics of Alopecia Areata at a Tertiary Care Center in Saudi Arabia. Dermatol Res Pract. 2020; 2020: 7194270.
- Sharma VK, Kumar B, Dawn G. A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol. 1996; 13(5): 372–377.
- Nanda A, Al-Fouzan AS, Al-Hasawi F. Alopecia areata in children: a clinical profile. Pediatr Dermatol. 2002; 19(6): 482–485.
- Sharma VK, Dawn G, Kumar B. Profile of alopecia areata in Northern India. Int J Dermatol. 1996; 35(1): 22–27.
- Tan E, Tay YK, Goh CL, et al. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians. Int J Dermatol. 2002; 41(11): 748–753.
